Stay updated with breaking news from Rostate C. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
These tests would not replace routine screening but help screen patients with no symptoms or nonspecific signs for cancers for which we could not otherwise screen, says an oncologist.
COSMOS trial results in patients with psoriatic arthritis fit with the expectation that "people who've previously failed a TNF inhibitor might be a little less likely to respond to guselkumab."